V. Ondet

Corrélation des altérations génétiques à l’agressivité anatomo-pathologique des carcinomes urothéliaux de la vessie : performance du test BCA-1

O. Cussenot, O. Traxer, S. Doizi, 2017 .

Detection of specific chromosomal aberrations in urine using BCA-1 (oligo-CGH-array) enhances diagnostic sensitivity and predicts the aggressiveness of non-muscle-invasive bladder transitional cell carcinoma

G. Cancel-Tassin, O. Cussenot, M. Rouprêt, 2013, World Journal of Urology.

Diagnosis of prostate cancer in one day: The benefits of cytology in tumour detection

G. Cancel-Tassin, O. Cussenot, E. Compérat, 2020, Cytopathology : official journal of the British Society for Clinical Cytology.

Olfactory detection of prostate cancer by dogs sniffing urine: a step forward in early diagnosis.

Olivier Cussenot, G. Cancel-Tassin, O. Cussenot, 2011, European urology.

Germline genetic variations at 11q13 and 12p11 locus modulate age at onset for renal cell carcinoma.

G. Cancel-Tassin, O. Cussenot, M. Rouprêt, 2014, The Journal of urology.

Assessment of Xpert Bladder Cancer Monitor test performance for the detection of recurrence during non-muscle invasive bladder cancer follow-up

G. Cancel-Tassin, O. Cussenot, M. Rouprêt, 2021, World Journal of Urology.

Impact of Body Mass Index, Age, Prostate Volume, and Genetic Polymorphisms on Prostate-specific Antigen Levels in a Control Population.

D. Cox, G. Cancel-Tassin, O. Cussenot, 2016, European urology.

Clinical performance of magnetic resonance imaging and biomarkers for prostate cancer diagnosis in men at high genetic risk

F. Hamdy, G. Cancel-Tassin, O. Cussenot, 2023, BJU international.